A 21-month-old boy came to our attention because of pneumonia. His weight increased before presentation, and his blood test results showed hyponatremia (116 mEq/L), low plasma osmolarity (241 mOsm/L), and high urine osmolarity (435 mOsm/L). He was treated with 0.9% sodium chloride solution and intravenous furosemide, and sodium levels rose up to 135 mEq/L in 36 hours. No standard treatment is available for severe hyponatremia in children. The use of vaptans in pediatric patients is described in literature, but it lacks evidence about safety and effectiveness. We suggest that furosemide administration plus salt replacement is effective in restoring normal values of plasma sodium concentration in severe euvolemic and hypervolemic hyponatremia.
Treatment of Severe Hypervolemic Hyponatremia in a Child with Pneumonia / T. Genoni, R. Tenconi, G. Bertolozzi, E.A. Laicini, G. Tardini, F. Vianello, E. Leva, G.P. Milani, E.F. Fossali. - In: PEDIATRIC EMERGENCY CARE. - ISSN 0749-5161. - 32:6(2016 Jun), pp. 390-391. [10.1097/PEC.0000000000000823]
Treatment of Severe Hypervolemic Hyponatremia in a Child with Pneumonia
T. GenoniPrimo
;R. TenconiSecondo
;F. Vianello;E. Leva;G.P. MilaniPenultimo
;
2016
Abstract
A 21-month-old boy came to our attention because of pneumonia. His weight increased before presentation, and his blood test results showed hyponatremia (116 mEq/L), low plasma osmolarity (241 mOsm/L), and high urine osmolarity (435 mOsm/L). He was treated with 0.9% sodium chloride solution and intravenous furosemide, and sodium levels rose up to 135 mEq/L in 36 hours. No standard treatment is available for severe hyponatremia in children. The use of vaptans in pediatric patients is described in literature, but it lacks evidence about safety and effectiveness. We suggest that furosemide administration plus salt replacement is effective in restoring normal values of plasma sodium concentration in severe euvolemic and hypervolemic hyponatremia.File | Dimensione | Formato | |
---|---|---|---|
GenoniFossali_PediatricEmergencyCare_TreatmentSevere_2016.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
103.43 kB
Formato
Adobe PDF
|
103.43 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.